Chemours (NYSE:CC) Given New $19.00 Price Target at Barclays
Chemours (NYSE:CC – Get Free Report) had its price objective lowered by research analysts at Barclays from $23.00 to $19.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s target price indicates a potential upside of 20.06% from the stock’s current […]
